Sullivan Gregory M Insider Trades

Insider Trading History

Track insider trading activity for Sullivan Gregory M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $445k 39,011 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$557k 39,011 shares
$14.29
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $445k 39,012 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$557k 39,012 shares
$14.29
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $331k 29,017 shares
Last Trade
Feb 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$234k 29,017 shares
$8.05
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $331k 29,017 shares
Last Trade
Feb 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$234k 29,017 shares
$8.05
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Feb 05, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$0 0 shares
$14.98
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $4.08M 358,000 shares
Last Trade
Feb 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$422M 358,000 shares
$1,177.60
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $4.08M 358,000 shares
Last Trade
Feb 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$422M 358,000 shares
$1,177.60
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $2.51M 220,000 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.22B 220,000 shares
$14,622.02
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $14.3M 1,250,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165B 1,250,000 shares
$132,352.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $14.3M 1,250,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165B 1,250,000 shares
$132,352.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $14.3M 1,250,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165B 1,250,000 shares
$132,352.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $14.3M 1,250,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165B 1,250,000 shares
$132,352.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $8.55M 750,000 shares
Last Trade
Feb 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$586B 750,000 shares
$780,800.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $8.55M 750,000 shares
Last Trade
Feb 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$586B 750,000 shares
$780,800.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $715k 62,727 shares
Last Trade
Jan 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.8B 41,322 shares
$504,320.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $244k 21,405 shares
Last Trade
Aug 17, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.2B 20,000 shares
$659,200.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $5.7M 500,000 shares
Last Trade
May 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$246B 500,000 shares
$492,800.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $5.7M 500,000 shares
Last Trade
May 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$246B 500,000 shares
$492,800.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $445k 39,000 shares
Last Trade
Feb 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.1B 39,000 shares
$258,816.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Medical Officer
Holding Value $445k 39,000 shares
Last Trade
Feb 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.1B 39,000 shares
$258,816.00
$11.40

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up